TLR4 and soft tissue sarcoma: Is intratumoral toll-like receptor 4 agonist glycopyranosyl lipid A in stable-emulsion formulation (GLA-SE) injection with radiotherapy an effective and feasible treatment for patients with advanced soft tissue sarcoma (STS)?